Denmark Confronts U.S. Pharma Pricing Turmoil
Published on: May 16, 2025, 10:07 p.m. | Source: Devdiscourse
The executive order by U.S. President Donald Trump, demanding lower drug prices, poses challenges for Danish pharma firms. The order, deemed by Denmark's business minister as detrimental, stresses immediate pricing targets with potential tariffs. Trump's strategy impacts substantial investments and trade dynamics in the life sciences sector.
